It should not be used with other GLP-1 medications or Tirzepatide, and other diabetes medicine doses may need adjustment to lower the risk of low blood sugar
Semaglutide injection activates GLP-1 receptors in your brain and gut to reduce hunger and slow stomach emptying, which typically causes mild to moderate side effects in the first 46 weeks of treatment
10.1096/fj.13-245472 178 RodriguesP.LimbackD.McGinnisL
Support the Foundations: Focus first on clean, anti-inflammatory nutrition, mitochondrial support, and restoring gut health
Real Treatments with Real Results Lose weight up to 15-20% On average, people on semaglutide lose 15-20% of their weight in a year Video Testimonials Videos of our Happy Customers See how our patients talk about their experience with InjectCos medical weight loss program
EClinicalMedicine 2024;72:102624